Washington Examiner
US · 2 hrs ago
✦ 72→ Right
Shut down the FDA’s failed GLP-1 green list
72Quality
0Ratings
0Comments
AI Analysis
Quality 72/100
Partisan intensity 68/100
ObjectivePartisan
→ Right ⚠ Misleading headline
The Washington Examiner reports on FDA manufacturing warnings against a Chinese GLP-1 ingredient supplier, arguing this demonstrates problems with FDA oversight of GLP-1 drugs and calling for stricter regulation or elimination of the agency's approval processes.
Shut down the FDA’s failed GLP-1 green list
People taking GLP-1 drugs deserve to know exactly what is being injected into their bodies. A new Food and Drug Administration warning letter shows why they may not. The FDA warned Harbin Jixianglong Biotech, a Chinese manufacturer tied to GLP-1 active pharmaceutical ingredients, over serious manufacturing and labeling violations. Most alarming, the company was placed […]
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!